相关实验视频
Updated: Jul 13, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.8K
超越肥胖症:与瘦肉代谢功能障碍相关的脂肪肝炎从揭示分子病原体到治疗进步
Indrajit Bhattacharya1, Deep Kumar Maity1, Amit Kumar1
1Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, Chunilal Bhawan, 168 Maniktala Main Road, Kolkata, 700054, West Bengal, India.
Naunyn-Schmiedeberg's archives of pharmacology
|May 14, 2025
概括
代谢功能障碍相关的脂肪肝疾病 (MAFLD),以前称为NAFLD,通过遗传和环境因素影响瘦个体. 了解精益MAFLD的理解
科学领域:
- 肝病学和代谢障碍 肝病和代谢障碍
- 遗传学和表观遗传学
- 分子生物学分子生物学
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD),以前称为NAFLD,是一个日益严重的全球健康问题.
- MAFLD包括一系列的肝脏疾病,从简单的肥胖症到非酒精性肥胖肝炎 (NASH),其特点是炎症和纤维化.
- 瘦身MAFLD具有独特的风险因素,包括内脏脂肪和并发症,与肥胖MAFLD不同.
研究的目的:
- 综合审查瘦肉MAFLD的分子和遗传病理生理学.
- 探索结合临床表型和基因组分析的诊断方法,用于瘦身MAFLD.
- 阐明瘦身MAFLD的治疗方面.
主要方法:
- 对遗传倾向的审查,包括关键基因如PNPLA3,TM6SF2和HSD17B13.
- 对表观遗传修饰的分析,重点是脂质代谢基因中的DNA甲基化模式.
- 对瘦肉MAFLD研究的饮食诱导和遗传动物模型的检查.
主要成果:
- 像PNPLA3和TM6SF2这样的基因中的遗传变异对肥胖独立的MAFLD有显著的贡献.
- 表观遗传变化,特别是PEMT低甲基化,与MAFLD病变发生有关.
- 动物模型提供了对精益MAFLD进展和治疗策略的关键见解.
结论:
- 精益MAFLD的发病包括遗传,表观遗传,生活方式和环境因素之间的复杂相互作用.
- 基因组分析以及详细的临床表型是诊断瘦肉MAFLD的必要条件.
- 对分子诊断和向治疗的进一步研究对于管理精益MAFLD至关重要.
相关概念视频
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...